| MeSH term | MeSH ID | Detail |
|---|---|---|
| Acute Kidney Injury | D058186 | 34 associated lipids |
| Osteitis | D010000 | 10 associated lipids |
| Dog Diseases | D004283 | 5 associated lipids |
| Osteomyelitis | D010019 | 10 associated lipids |
| Coronary Disease | D003327 | 70 associated lipids |
| Pancreatitis | D010195 | 10 associated lipids |
| Acne Vulgaris | D000152 | 35 associated lipids |
| Skin Ulcer | D012883 | 6 associated lipids |
| Eyelid Diseases | D005141 | 4 associated lipids |
| Multiple Myeloma | D009101 | 13 associated lipids |
Azithramycine
Azithramycine is a lipid of Polyketides (PK) class. Azithramycine is associated with abnormalities such as Respiratory Tract Infections, Pneumonia, Lower respiratory tract infection, Infection and Nonspecific urethritis. The involved functions are known as Lysis, Selection, Genetic, Mutation, Relapse and Adaptation. Azithramycine often locates in Blood, Respiratory System, Genitourinary system, Back and Chest. The associated genes with Azithramycine are Genes, rRNA, Genome, RPL22 gene, OPRM1 gene and tryptic soy broth. The related lipids are Liposomes, Phosphatidylserines, Promega, Lipopolysaccharides and Steroids. The related experimental models are Mouse Model, Knock-out and Tissue Model.
Cross Reference
Introduction
To understand associated biological information of Azithramycine, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Azithramycine?
Azithramycine is suspected in Infection, Pneumonia, Trachoma, Respiratory Tract Infections, Gonorrhea, Infectious disease of lung and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
- Antimicrob. Agents Chemother. (156)
- Clin. Infect. Dis. (64)
- J. Antimicrob. Chemother. (50)
- Others (435)
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Azithramycine
PubChem Associated disorders and diseases
What pathways are associated with Azithramycine
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Azithramycine?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
- Antimicrob. Agents Chemother. (66)
- J. Antimicrob. Chemother. (25)
- Clin. Infect. Dis. (13)
- Others (151)
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Azithramycine?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Azithramycine?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with Azithramycine?
Related references are published most in these journals:
- Antimicrob. Agents Chemother. (44)
- J. Antimicrob. Chemother. (18)
- Clin. Infect. Dis. (10)
- Others (126)
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Azithramycine?
Mouse Model
Mouse Model are used in the study 'Azithromycin increases in vitro fibronectin production through interactions between macrophages and fibroblasts stimulated with Pseudomonas aeruginosa.' (Cory TJ et al., 2013), Mouse Model are used in the study 'Efficacy of azithromycin, clarithromycin and beta-lactam agents against experimentally induced bronchopneumonia caused by Haemophilus influenzae in mice.' (Miyazaki S et al., 2001), Mouse Model are used in the study 'Oral anti-pneumococcal activity and pharmacokinetic profiling of a novel peptide deformylase inhibitor.' (Gross M et al., 2004), Mouse Model are used in the study 'Inhibition of quorum sensing in Pseudomonas aeruginosa by azithromycin and its effectiveness in urinary tract infections.' (Bala A et al., 2011) and Mouse Model are used in the study 'Enhanced efficacy of single-dose versus multi-dose azithromycin regimens in preclinical infection models.' (Girard D et al., 2005).
Knock-out
Knock-out are used in the study 'Influence of rhlR and lasR on Polymyxin Pharmacodynamics in Pseudomonas aeruginosa and Implications for Quorum Sensing Inhibition with Azithromycin.' (Bulman ZP et al., 2017) and Knock-out are used in the study 'Azithromycin in Pseudomonas aeruginosa biofilms: bactericidal activity and selection of nfxB mutants.' (Mulet X et al., 2009).
Tissue Model
Tissue Model are used in the study 'Development of a population pharmacokinetic model characterizing the tissue distribution of azithromycin in healthy subjects.' (Zheng S et al., 2014).
Related references are published most in these journals:
| Model | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
NCBI Entrez Crosslinks
All references with Azithramycine
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Bellon H et al. | Interleukin-1α induced release of interleukin-8 by human bronchial epithelial cells in vitro: assessing mechanisms and possible treatment options. | 2017 | Transpl. Int. | pmid:28078769 |
| Geudens N et al. | Azithromycin reduces airway inflammation in a murine model of lung ischaemia reperfusion injury. | 2008 | Transpl. Int. | pmid:18435685 |
| Verleden GM et al. | Obliterative bronchiolitis following lung transplantation: from old to new concepts? | 2009 | Transpl. Int. | pmid:19490538 |
| Verleden GM et al. | Montelukast for bronchiolitis obliterans syndrome after lung transplantation: a pilot study. | 2011 | Transpl. Int. | pmid:21401732 |
| Verleden GM et al. | Current views on chronic rejection after lung transplantation. | 2015 | Transpl. Int. | pmid:25857869 |
| Kwun WH et al. | Effect of azithromycin in the treartment of cyclosporine-induced gingival hyperplasia in renal transplant recipients. | 2003 | Transplant. Proc. | pmid:12591416 |
| Nafar M et al. | A comparison between the efficacy of systemic and local azithromycin therapy in treatment of cyclosporine induced gingival overgrowth in kidney transplant patients. | 2003 | Transplant. Proc. | pmid:14612094 |
| Puig JM et al. | Treatment of gingival hyperplasia secondary to cyclosporine by the new macrolide azithromycin. | 1997 | Transplant. Proc. | pmid:9270772 |
| Wirnsberger GH et al. | Effect of antibiotic treatment with azithromycin on cyclosporine A-induced gingival hyperplasia among renal transplant recipients. | 1998 | Transplant. Proc. | pmid:9723411 |
| Boran M et al. | Improvement in cyclosporine A associated gingival hyperplasia with azithromycin therapy. | 1996 | Transplant. Proc. | pmid:8769234 |
| Citterio F et al. | Azithromycin treatment of gingival hyperplasia in kidney transplant recipients is effective and safe. | 2001 | Transplant. Proc. | pmid:11377476 |
| Verleden GM et al. | Efficacy of total lymphoid irradiation in azithromycin nonresponsive chronic allograft rejection after lung transplantation. | 2009 | Transplant. Proc. | pmid:19545735 |
| Tokgöz B et al. | Effects of azithromycin on cyclosporine-induced gingival hyperplasia in renal transplant patients. | 2004 | Transplant. Proc. | pmid:15621128 |
| Shullo MA et al. | Elevated tacrolimus levels associated with intravenous azithromycin and ceftriaxone: a case report. | 2010 | Transplant. Proc. | pmid:20620540 |
| Lendermon EA et al. | Azithromycin Fails to Prevent Accelerated Airway Obliteration in T-bet Mouse Lung Allograft Recipients. | 2018 | Transplant. Proc. | pmid:29880387 |
| Nash MM and Zaltzman JS | Efficacy of azithromycin in the treatment of cyclosporine-induced gingival hyperplasia in renal transplant recipients. | 1998 | Transplantation | pmid:9665078 |
| Verleden GM and Dupont LJ | Azithromycin therapy for patients with bronchiolitis obliterans syndrome after lung transplantation. | 2004 | Transplantation | pmid:15167610 |
| Imai N et al. | A case of Campylobacter enteritis in a renal transplant recipient. | 2013 | Transplantation | pmid:23774778 |
| Vos R et al. | Anti-inflammatory and immunomodulatory properties of azithromycin involved in treatment and prevention of chronic lung allograft rejection. | 2012 | Transplantation | pmid:22461039 |
| Gottlieb J et al. | Long-term azithromycin for bronchiolitis obliterans syndrome after lung transplantation. | 2008 | Transplantation | pmid:18192909 |
| Verleden SE et al. | Bronchiolitis obliterans syndrome and restrictive allograft syndrome: do risk factors differ? | 2013 | Transplantation | pmid:23425818 |
| Wirnsberger GH and Pfragner R | Comment on "Efficacy of azithromycin in the treatment of cyclosporine-induced gingival hyperplasia in renal transplant recipients" by Nash and Zaltzman. | 1999 | Transplantation | pmid:10342326 |
| Requena-Méndez A et al. | Enteric fever in Barcelona: Changing patterns of importation and antibiotic resistance. | Travel Med Infect Dis | pmid:27890811 | |
| Dave J et al. | Trends in antibiotic susceptibility of enteric fever isolates in East London. | Travel Med Infect Dis | pmid:25964222 | |
| Baneke A | Review: Targeting trachoma: Strategies to reduce the leading infectious cause of blindness. | 2012 | Travel Med Infect Dis | pmid:22326056 |
| Swanson RN et al. | Once-daily azithromycin for 3 days compared with clarithromycin for 10 days for acute exacerbation of chronic bronchitis: a multicenter, double-blind, randomized study. | 2005 | Treat Respir Med | pmid:15725048 |
| Cymbala AA et al. | The disease-modifying effects of twice-weekly oral azithromycin in patients with bronchiectasis. | 2005 | Treat Respir Med | pmid:15813663 |
| Zervos M et al. | Comparative efficacies and tolerabilities of intravenous azithromycin plus ceftriaxone and intravenous levofloxacin with step-down oral therapy for hospitalized patients with moderate to severe community-acquired pneumonia. | 2004 | Treat Respir Med | pmid:15606222 |
| What's in the water? | 1995 Mar-Apr | Treat Rev | pmid:11362299 | |
| Azithro once a week for MAC. | 1998 | TreatmentUpdate | pmid:11365625 | |
| Infection fighters. MAC prevention takes a holiday. | 2000 | TreatmentUpdate | pmid:12132450 | |
| Noedl H | ABC - antibiotics-based combinations for the treatment of severe malaria? | 2009 | Trends Parasitol. | pmid:19819757 |
| Chang AB et al. | Antibiotics for bronchiectasis exacerbations in children: rationale and study protocol for a randomised placebo-controlled trial. | 2012 | Trials | pmid:22937736 |
| Pokharel S et al. | Co-trimoxazole versus azithromycin for the treatment of undifferentiated febrile illness in Nepal: study protocol for a randomized controlled trial. | 2017 | Trials | pmid:28969659 |
| Uzun S et al. | Influence of macrolide maintenance therapy and bacterial colonisation on exacerbation frequency and progression of COPD (COLUMBUS): study protocol for a randomised controlled trial. | 2012 | Trials | pmid:22682323 |
| Chang AB et al. | Bronchiectasis exacerbation study on azithromycin and amoxycillin-clavulanate for respiratory exacerbations in children (BEST-2): study protocol for a randomized controlled trial. | 2013 | Trials | pmid:23421781 |
| Chang AB et al. | Randomized placebo-controlled trial on azithromycin to reduce the morbidity of bronchiolitis in Indigenous Australian infants: rationale and protocol. | 2011 | Trials | pmid:21492416 |
| Brittain C et al. | Gentamicin versus ceftriaxone for the treatment of gonorrhoea (G-TOG trial): study protocol for a randomised trial. | 2016 | Trials | pmid:27881151 |
| Bandyopadhyay R et al. | Effectiveness of treatment regimens for Typhoid fever in the nalidixic acid-resistant S. typhi (NARST) era in South India. | 2018 | Trop Doct | pmid:29495943 |
| Rajapakse S et al. | Drug treatment of scrub typhus. | 2011 | Trop Doct | pmid:21172901 |
| Fegan D et al. | Resurgence of yaws in Tanna, Vanuatu: time for a new approach? | 2010 | Trop Doct | pmid:20305095 |
| Mahajan SK et al. | Scrub typhus and malaria co-infection causing severe sepsis. | 2014 | Trop Doct | pmid:24249027 |
| Fegan D et al. | Tropical leg ulcers in children: more than yaws. | 2016 | Trop Doct | pmid:26289420 |
| Kuper H et al. | Participatory evaluations of trachoma control programmes in eight countries. | 2005 | Trop. Med. Int. Health | pmid:16045463 |
| Wong RP et al. | In vitro sensitivity of Plasmodium falciparum to conventional and novel antimalarial drugs in Papua New Guinea. | 2010 | Trop. Med. Int. Health | pmid:20070627 |
| Edwards T et al. | Risk factors for active trachoma and Chlamydia trachomatis infection in rural Ethiopia after mass treatment with azithromycin. | 2008 | Trop. Med. Int. Health | pmid:18282237 |
| Luntamo M et al. | The effect of antenatal monthly sulphadoxine-pyrimethamine, alone or with azithromycin, on foetal and neonatal growth faltering in Malawi: a randomised controlled trial. | 2013 | Trop. Med. Int. Health | pmid:23432801 |
| Hart JD et al. | Effect of azithromycin mass drug administration for trachoma on spleen rates in Gambian children. | 2014 | Trop. Med. Int. Health | pmid:24433194 |
| Chico RM and Chandramohan D | Intermittent preventive treatment of malaria in pregnancy: at the crossroads of public health policy. | 2011 | Trop. Med. Int. Health | pmid:21477099 |
| de Vries PI et al. | Short course of azithromycin/artesunate against falciparum malaria: no full protection against recrudescence. | 1999 | Trop. Med. Int. Health | pmid:10402979 |